Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2012; 18(11): 1208-1215
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1208
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1208
Table 1 Clinical and pathological data of patients with gallbladder adenomas, adenocarcinoma and its putative precursor lesions
| Lesion | Sex | Age (yr, mean ± SD) |
| Normal mucosa (n = 5) | F (5) | 54.6 ± 9.0 |
| Pyloric adenoma (n = 15) | F (13)/M (2) | 55.2 ± 3.5 |
| Intestinal adenoma (n = 6) | F (6) | 68.5 ± 1.7 |
| Pyloric-type metaplasia (n = 20) | F (20) | 51.5 ± 3.2 |
| Intestinal metaplasia (n = 24) | F (24) | 50.0 ± 3.4 |
| Carcinoma in situ (n = 10) | F (9)/M (1) | 65.8 ± 2.5 |
| Invasive carcinoma (n = 12) | F (9)/M (3) | 66.0 ± 3.8 |
- Citation: Toledo C, Matus CE, Barraza X, Arroyo P, Ehrenfeld P, Figueroa CD, Bhoola KD, del Pozo M, Poblete MT. Expression of HER2 and bradykinin B1 receptors in precursor lesions of gallbladder carcinoma. World J Gastroenterol 2012; 18(11): 1208-1215
- URL: https://www.wjgnet.com/1007-9327/full/v18/i11/1208.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i11.1208